Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)

NZE:FPH Financials Overview

Financials in millions NZD. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	2,308	2,308	2,021	1,743	1,581	1,682
Revenue Growth	6.96%	14.22%	15.96%	10.23%	-5.98%	-14.69%
Gross Profit Gross Profit Growth	1,470	1,470	1,271	1,044	938.4	1,053
Operating Income Operating Income Growth	636.4	636.4	509.6	353.4	332.2	505.6
Net Income Net Income Growth	468.5	468.5	377.2	132.6	250.3	376.9
Earnings Per Share EPS Growth	0.79	0.79	0.64	0.23	0.43	0.65
EPS Growth	7.33%	24.10%	182.74%	-47.44%	-33.85%	-28.10%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Hospital Products Hospital Products Growth	1,505	1,505	1,280	1,088	1,024	1,207
Homecare Products Homecare Products Growth	802.7	802.7	739.9	652.3	553.8	469.5
Distributed and Other Products Distributed and Other Products Growth	0.63	0.7	0.8	2.6	3.8	5.1

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	461.1	461.1	264.5	82	121.5	290
Total Debt Total Debt Growth	146.1	146.1	153.3	189.1	145.8	104.3
Net Cash (Debt) Net Cash Growth	315	315	111.2	-107.1	-24.3	185.7
Net Cash Growth	107.51%	183.27%	-	-	-	-27.97%
Net Cash Per Share Net Cash Per Share Growth	0.53	0.53	0.19	-0.18	-0.04	0.32

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	663.2	663.2	548.6	429.6	238.2	324.3
Capital Expenditures CapEx Growth	-172.8	-172.8	-73.6	-316.8	-187.8	-138.4
Free Cash Flow Free Cash Flow Growth	490.4	490.4	475	112.8	50.4	185.9
Free Cash Flow Growth	3.16%	3.24%	321.10%	123.81%	-72.89%	-60.03%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	63.69%	63.69%	62.89%	59.93%	59.35%	62.60%
Operating Margin	27.57%	27.57%	25.21%	20.28%	21.01%	30.06%
Pretax Margin	27.36%	27.36%	24.90%	13.52%	20.75%	29.98%
Profit Margin	20.29%	20.29%	18.66%	7.61%	15.83%	22.41%
FCF Margin	21.24%	21.24%	23.50%	6.47%	3.19%	11.05%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	0.520	0.520	0.425	0.415	0.405	0.395
Dividend Per Share Growth	22.35%	22.35%	2.41%	2.47%	2.53%	3.95%
Dividend Yield	1.13%	1.39%	1.27%	1.62%	1.52%	1.62%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	58.26	46.87	52.12	112.96	61.67	37.30
Forward PE	48.98	42.22	48.68	47.38	52.48	39.67
P/FCF Ratio	55.33	44.78	41.39	132.79	306.27	75.61
PS Ratio	11.75	9.51	9.73	8.60	9.76	8.36

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: May 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Semi-annually

Last checked:

Nov 1, 2026

Data Sources Report a data error